Dichloro-{bis(pyrazol-1-yl)}palladium(ii) complexes: Structures of a dmso solvated dichloro-{bis(3,5-dimethylpyrazol-1-yl)acetic acid}palladium(ii) and dichloro-{bis(3,5-ditertbutylpyrazol-1-yl)methane}palladium(ii)

Two new palladium(II) complexes, dichloro-{bis(3,5-dimethylpyrazol-1-yl) acetic acid}palladium(II)PdCl₂(3,5-Me₂bpza)], (1) (3,5-Me₂bpza = 3,5-dimethylpyrazol-1-yl)acetic acid) and dichloro-{bis(3,5-ditertbutylpyrazol-1-yl)acetic acid}palladium(II), [PdCl ₂(3,5-^tBu₂bpza)], (2a) [3,5- ^t Bu₂bpza = 3,5-ditertiarybutylpyrazol-1-yl)acetic acid] complexes, were synthesized from the reactions of pyrazol-1-yl ligands with palladium salts. Attempts to crystallize 2a led to a hydrolyzed product, dichloro-{3,5-ditertbutylpyrazol-1-yl}palladium(II) (2b), in which the acetic acid moiety in the ligand backbone of 1 is lost. Both complexes 1 and 2b have been characterized by single-crystal X-ray crystallography. Both complexes crystallized in triclinic system (P - 1 space group). The cell parameters are: complex 1 (a = 8.7960(14) Å, b = 16.238(2) Å, c = 16.430(2) Å, α = 78.038(10)°, β = 77.817(11)°, γ = 89.970(10)°) and complex 2b (a = 10.1492(2) Å, b = 12.4001(2) Å, c = 13.108(3) Å, α = 103.0690(10)°, β = 97.4120(10)°, γ = 107.2450(10)°). The asymmetric unit of 1 contains two crystallographic independent monomeric units of 1 and three molecules of DMSO solvent, whilst that of 2b has got one monomeric unit with one molecule of chloroform solvent.